Digital pharmacy startup Medly is closing its doors at the end of February, two employees confirmed. A U. S. Bankruptcy Court judge in Delaware on Monday approved the sale of Medly’s pharmacy assets, including its patient data, pharmacy records and prescription drug inventory to Walgreens for $19.35 million. The sale did not include its retail […]
Medly Sells Assets to Walgreens for $19.3M Read More »
Analysts were generally bullish on CVS’ move to dig into primary care with the Oak Street Health acquisition. Major healthcare players are ramping up investments in value-based care offerings as a strategic play to control more of the healthcare dollar. Analyst Ryan Daniels and colleagues at William Blair wrote Wednesday that the CVS-Oak Street Health
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Mark Cuban and Amazon Are Shaking Up Generic Drugs Read More »
Americans tremble at the idea of losing their health coverage, but bypassing giant insurers saves some people serious money on prescriptions in a topsy-turvy system. Lower-cost options are starting to put pressure on middlemen who profit from an opaque business model. Read the full article: Mark Cuban and Amazon Are Shaking Up Generic Drugs //
Mark Cuban and Amazon Are Shaking Up Generic Drugs Read More »
You are unauthorized to view this page.
Can Amazon Disrupt the Pharmacy Industry? Read More »
Amazon has experimented with different projects in healthcare the past few years, but its current focus seems to be at the pharmacy counter — the digital one, at least. Its latest declaration to the industry came last week when it debuted RxPass, a $5-a-month generic drug plan for Prime members. With the new service, “Amazon
Can Amazon Disrupt the Pharmacy Industry? Read More »
You are unauthorized to view this page.
MedAvail Announces Sale of Pharmacy Assets to CVS Pharmacy Read More »
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative technology-enabled pharmacy company, today announced it has entered into a definitive agreement with CVS Pharmacy, Inc., on behalf of itself and its subsidiaries and affiliates (“CVS”), for the sale of certain assets of MedAvail’s SpotRx pharmacies (the “CVS Transaction”). In connection with the CVS Transaction, MedAvail has
MedAvail Announces Sale of Pharmacy Assets to CVS Pharmacy Read More »
You are unauthorized to view this page.
Walgreens Weighs $2B Sale of Pharmacy Automation Unit Read More »
You are unauthorized to view this page.
Amazon Rolls Out Generic Drug Subscription Service Read More »
